The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV*
Open accessAbstract
Background: Metabolic diseases are frequently observed in HIV‐infected persons and, as the risk of contracting these diseases is age‐related, their prevalence will increase in the future as a consequence of the benefits of antiretroviral therapy (ART). Summary of guidelines: All HIV‐infected persons should be screened at regular intervals for a history of metabolic disease, dyslipidaemia, diabetes mellitus, hypertension and alteration of body composition; cardiovascular risk and renal function should also be assessed. Efforts to prevent cardiovascular disease will vary in intensity depending on an individual's absolute risk of ischaemic heart disease and should be comprehensive in nature. Lifestyle interventions should focus on counselling to stop smoking, modify diet and take regular exercise. A healthy diet, exercise and maintaining normal body weight tend to reduce dyslipidaemia; if not effective, a change of ART should be considered, followed by use of lipid‐lowering medication in high‐risk patients. A pre‐emptive switch from thymidine analogues is recommended to reduce the risk of development or progression of lipoatrophy. Intra‐abdominal fat accumulation is best managed by exercise and diet. Prevention and management of type 2 diabetes mellitus and hypertension follow guidelines used in the general population. When using medical interventions to prevent and/or treat metabolic disease(s), impairment of the efficacy of ART should be avoided by considering the possibility of pharmacokinetic interactions and compromised adherence. Specialists in HIV and specialists in metabolic diseases should consult each other, in particular in difficult‐to‐treat cases. Conclusion: Multiple and relatively simple approaches exist to prevent metabolic diseases in HIV‐infected persons; priority should be given to patients at high risk of contracting these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“according to the European AIDS Clinical Society simvastatin is contraindicated in patients receiving ritonavir-boosted protease inhibitorbased antiretroviral treatment 214”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [214]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary
Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,644
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
Grinspoon, S. K., & Carr, A. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041811 · Cited by 1,073
Dubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D. L., & Glesby, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/378131 · Cited by 578
Gupta, S. K., Eustace, J. A., Winston, J. A., Boydstun, I. I., Ahuja, T. S., Rodriguez, R. A., Tashima, K. T., Roland, M. E., Franceschini, N., Palella, F. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430257 · Cited by 577
Mallon, P. W. G., Miller, J., Cooper, D. A., & Carr, A. D. (2003) · AIDS · doi:10.1097/00002030-200305020-00005 · Cited by 313
Research works printed but not linked: 3
- Ryden L, 2007, Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre‐diabetes, and cardiovascular diseases, Eur Heart J, 28, 88
- American Diabetes Association., 2007, Position statement, standards of medical care in diabetes – 2007, 30, S48
- Cifkova R, 2003, ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians, 2003 ESH/ESC hypertension guidelines, 21, 1779
Cited by
Sorted by citations
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Antiretroviral Treatment of Adult HIV Infection
Thompson, M., Aberg, J. A., Hoy, J., Telenti, A., Benson, C., Cahn, P. E., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,493
Self-citationAntiretroviral Treatment of Adult HIV Infection
Hammer, S. M., Eron, J. J., Reiss, P., Schooley, R. T., Thompson, M., Walmsley, S. L., Cahn, P. E., Fischl, M. A., Gatell, J. M., Hirsch, M., et al. (2008) · JAMA · doi:10.1001/jama.300.5.555 · Cited by 1,117
Self-citationNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Metadata
- Authors
- Lundgren, J., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., Martinez, E., Nair, D., Powderly, W., Reiss, P., Sutinen, J., Vigano, A., & the EACS Executive Committee
- Affiliations
- University Hospital of Basel (CH)
- Medizinische Hochschule Hannover (DE)
- University of Modena and Reggio Emilia (IT)
- Pitié-Salpêtrière Hospital (FR)
- The Royal Free Hospital (GB)
- Amsterdam UMC Location University of Amsterdam (NL)
- Helsinki University Hospital (FI)
- Venue
- HIV Medicine
- Publisher
- Wiley
- Published
- 2008-01-31
- Volume
- 9
- Issue
- 2
- Pages
- 72-81
- ISSN
- 1464-2662 (ISSN-L)
- 1468-1293
- OpenAlex
- W2032218832
- Cited by
- 210
- References
- 18
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 9 · 2018: 5 · 2017: 8 · 2016: 14 · 2015: 14 · 2014: 13 · 2013: 22 · 2012: 19
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- HIV Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- dyslipidemia, type 2 diabetes, hypertension, lipoatrophy, intra-abdominal fat, cardiovascular risk, antiretroviral therapy, lipid-lowering therapy, lifestyle intervention, body composition, renal function, pharmacokinetic interactions, medication adherence, screening
- MeSH terms
- Cardiovascular Diseases, Drug Interactions, Humans, Life Style, Metabolic Diseases, HIV Infections, Polypharmacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
